AiON
← Medical directoryActive ingredient

Lixisenatide

GLP-1 receptor agonist named in the Wegovy tablets patient information leaflet as a medicine that should not be combined with oral semaglutide because it belongs to the same class.

Institutional endorsement by Clínica Evolution

Medical guides

Keep reading

This entry is for information. Your case requires an individual medical assessment.